A Retraction of the Original Research Article
Paeonol suppresses proliferation and motility of non-small-cell lung cancer cells by disrupting STAT3/NF-κB signaling
by Zhang L, Chen W-X, Li L-L, Cao Y-Z, Geng Y-D, Feng X-J, Wang A-Y, Chen Z-L, Lu Y and Shen A-Z (2020). Front. Pharmacol. 11:572616. doi: 10.3389/fphar.2020.572616
The journal retracts the 12 November 2020 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.
This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.
Frontiers would like to thank Sholto David for contacting the journal regarding the published article.
Citation: Frontiers Editorial Office (2026) Retraction: Paeonol suppresses proliferation and motility of non-small-cell lung cancer cells by disrupting STAT3/NF-κB signaling. Front. Pharmacol. 17:1781979. doi: 10.3389/fphar.2026.1781979
Received: 06 January 2026; Accepted: 06 January 2026;
Published: 27 January 2026.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2026 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==